NCI team details method to improve T cell therapies

A team led by NCI's Nicholas Restifo showed raising potassium levels or adding a citrate derivative when manufacturing adoptive T cell therapies could improve antitumor efficacy.

Reported

Read the full 261 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE